injections of 100 nmol kg 1 MK-801 ( n = 12 rats), 100 nmol kg 1 GLP-1 ( n = 12 rats), 100 nmol kg 1 GLP-1MK-801 ( n = 12 rats) or vehicle (isotonic saline, n = 13 rats) for three consecutive days while being offered the voluntary choice between chow and kaolin (a non-food product)
Never mix insulin and GLP-1 agonists in the same syringe unless specifically using a combination product designed for this purpose
Serena, G., D'Avino, P., & Fasano, A
Administering this peptide by injection or nasal spray is critical to ensuring high bioavailability, as DSIP cannot cross the epithelium-mimicking Caco-2 cell layer system
This led researchers to study semaglutides potential as a weight loss medication, particularly for non-diabetic individuals struggling with obesity
It can be a heartbreaking conversation, she says